Pre-order Enquiry
Request Free Sample
Global Radiopharmaceutical Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
SKU ID : QYR-15947540 | Publishing Date : 14-Jul-2020 | No. of pages : 132
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Radiopharmaceutical Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
1 Study Coverage1.1 Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceutical Revenue 2015-2026
2.1.2 Global Radiopharmaceutical Sales 2015-2026
2.2 Radiopharmaceutical Market Size by Region: 2020 Versus 2026
2.3 Radiopharmaceutical Sales by Region (2015-2026)
2.3.1 Global Radiopharmaceutical Sales by Region: 2015-2020
2.3.2 Global Radiopharmaceutical Sales Forecast by Region (2021-2026)
2.3.3 Global Radiopharmaceutical Sales Market Share by Region (2015-2026)
2.4 Radiopharmaceutical Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Radiopharmaceutical Revenue by Region: 2015-2020
2.4.2 Global Radiopharmaceutical Revenue Forecast by Region (2021-2026)
2.4.3 Global Radiopharmaceutical Revenue Market Share by Region (2015-2026)
3 Global Radiopharmaceutical by Manufacturers
3.1 Global Top Radiopharmaceutical Manufacturers by Sales
3.1.1 Global Radiopharmaceutical Sales by Manufacturer (2015-2020)
3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Radiopharmaceutical Manufacturers by Revenue
3.2.1 Global Radiopharmaceutical Revenue by Manufacturer (2015-2020)
3.2.2 Global Radiopharmaceutical Revenue Share by Manufacturer (2015-2020)
3.3 Global Radiopharmaceutical Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Radiopharmaceutical Manufacturers Covered: Ranking by Revenue
3.4.2 Global Radiopharmaceutical Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Radiopharmaceutical Manufacturing Base Distribution, Product Type
3.5.1 Radiopharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Radiopharmaceutical Product Type
3.5.3 Date of International Manufacturers Enter into Radiopharmaceutical Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bracco Imaging
4.1.1 Bracco Imaging Corporation Information
4.1.2 Bracco Imaging Description, Business Overview
4.1.3 Bracco Imaging Radiopharmaceutical Products Offered
4.1.4 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Bracco Imaging Radiopharmaceutical Revenue by Product
4.1.6 Bracco Imaging Radiopharmaceutical Revenue by Application
4.1.7 Bracco Imaging Radiopharmaceutical Revenue by Geographic Area
4.1.8 Bracco Imaging Radiopharmaceutical Revenue by Sales Channel
4.1.9 Bracco Imaging Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Radiopharmaceutical Products Offered
4.2.4 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Bayer Radiopharmaceutical Revenue by Product
4.2.6 Bayer Radiopharmaceutical Revenue by Application
4.2.7 Bayer Radiopharmaceutical Revenue by Geographic Area
4.2.8 Bayer Radiopharmaceutical Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Mallinckrodt
4.3.1 Mallinckrodt Corporation Information
4.3.2 Mallinckrodt Description, Business Overview
4.3.3 Mallinckrodt Radiopharmaceutical Products Offered
4.3.4 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Mallinckrodt Radiopharmaceutical Revenue by Product
4.3.6 Mallinckrodt Radiopharmaceutical Revenue by Application
4.3.7 Mallinckrodt Radiopharmaceutical Revenue by Geographic Area
4.3.8 Mallinckrodt Radiopharmaceutical Revenue by Sales Channel
4.3.9 Mallinckrodt Recent Development
4.4 Nordion
4.4.1 Nordion Corporation Information
4.4.2 Nordion Description, Business Overview
4.4.3 Nordion Radiopharmaceutical Products Offered
4.4.4 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Nordion Radiopharmaceutical Revenue by Product
4.4.6 Nordion Radiopharmaceutical Revenue by Application
4.4.7 Nordion Radiopharmaceutical Revenue by Geographic Area
4.4.8 Nordion Radiopharmaceutical Revenue by Sales Channel
4.4.9 Nordion Recent Development
4.5 Triad Isotopes
4.5.1 Triad Isotopes Corporation Information
4.5.2 Triad Isotopes Description, Business Overview
4.5.3 Triad Isotopes Radiopharmaceutical Products Offered
4.5.4 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Triad Isotopes Radiopharmaceutical Revenue by Product
4.5.6 Triad Isotopes Radiopharmaceutical Revenue by Application
4.5.7 Triad Isotopes Radiopharmaceutical Revenue by Geographic Area
4.5.8 Triad Isotopes Radiopharmaceutical Revenue by Sales Channel
4.5.9 Triad Isotopes Recent Development
4.6 Lantheus
4.6.1 Lantheus Corporation Information
4.6.2 Lantheus Description, Business Overview
4.6.3 Lantheus Radiopharmaceutical Products Offered
4.6.4 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Lantheus Radiopharmaceutical Revenue by Product
4.6.6 Lantheus Radiopharmaceutical Revenue by Application
4.6.7 Lantheus Radiopharmaceutical Revenue by Geographic Area
4.6.8 Lantheus Recent Development
4.7 IBA Group
4.7.1 IBA Group Corporation Information
4.7.2 IBA Group Description, Business Overview
4.7.3 IBA Group Radiopharmaceutical Products Offered
4.7.4 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.7.5 IBA Group Radiopharmaceutical Revenue by Product
4.7.6 IBA Group Radiopharmaceutical Revenue by Application
4.7.7 IBA Group Radiopharmaceutical Revenue by Geographic Area
4.7.8 IBA Group Recent Development
4.8 GE Healthcare
4.8.1 GE Healthcare Corporation Information
4.8.2 GE Healthcare Description, Business Overview
4.8.3 GE Healthcare Radiopharmaceutical Products Offered
4.8.4 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.8.5 GE Healthcare Radiopharmaceutical Revenue by Product
4.8.6 GE Healthcare Radiopharmaceutical Revenue by Application
4.8.7 GE Healthcare Radiopharmaceutical Revenue by Geographic Area
4.8.8 GE Healthcare Recent Development
4.9 China Isotope & Radiation
4.9.1 China Isotope & Radiation Corporation Information
4.9.2 China Isotope & Radiation Description, Business Overview
4.9.3 China Isotope & Radiation Radiopharmaceutical Products Offered
4.9.4 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.9.5 China Isotope & Radiation Radiopharmaceutical Revenue by Product
4.9.6 China Isotope & Radiation Radiopharmaceutical Revenue by Application
4.9.7 China Isotope & Radiation Radiopharmaceutical Revenue by Geographic Area
4.9.8 China Isotope & Radiation Recent Development
4.10 Jubilant Pharma
4.10.1 Jubilant Pharma Corporation Information
4.10.2 Jubilant Pharma Description, Business Overview
4.10.3 Jubilant Pharma Radiopharmaceutical Products Offered
4.10.4 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Jubilant Pharma Radiopharmaceutical Revenue by Product
4.10.6 Jubilant Pharma Radiopharmaceutical Revenue by Application
4.10.7 Jubilant Pharma Radiopharmaceutical Revenue by Geographic Area
4.10.8 Jubilant Pharma Recent Development
4.11 Eli Lilly
4.11.1 Eli Lilly Corporation Information
4.11.2 Eli Lilly Description, Business Overview
4.11.3 Eli Lilly Radiopharmaceutical Products Offered
4.11.4 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Eli Lilly Radiopharmaceutical Revenue by Product
4.11.6 Eli Lilly Radiopharmaceutical Revenue by Application
4.11.7 Eli Lilly Radiopharmaceutical Revenue by Geographic Area
4.11.8 Eli Lilly Recent Development
4.12 Advanced Accelerator Applications
4.12.1 Advanced Accelerator Applications Corporation Information
4.12.2 Advanced Accelerator Applications Description, Business Overview
4.12.3 Advanced Accelerator Applications Radiopharmaceutical Products Offered
4.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.12.5 Advanced Accelerator Applications Radiopharmaceutical Revenue by Product
4.12.6 Advanced Accelerator Applications Radiopharmaceutical Revenue by Application
4.12.7 Advanced Accelerator Applications Radiopharmaceutical Revenue by Geographic Area
4.12.8 Advanced Accelerator Applications Recent Development
4.13 SIEMENS
4.13.1 SIEMENS Corporation Information
4.13.2 SIEMENS Description, Business Overview
4.13.3 SIEMENS Radiopharmaceutical Products Offered
4.13.4 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.13.5 SIEMENS Radiopharmaceutical Revenue by Product
4.13.6 SIEMENS Radiopharmaceutical Revenue by Application
4.13.7 SIEMENS Radiopharmaceutical Revenue by Geographic Area
4.13.8 SIEMENS Recent Development
4.14 Dongcheng
4.14.1 Dongcheng Corporation Information
4.14.2 Dongcheng Description, Business Overview
4.14.3 Dongcheng Radiopharmaceutical Products Offered
4.14.4 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Dongcheng Radiopharmaceutical Revenue by Product
4.14.6 Dongcheng Radiopharmaceutical Revenue by Application
4.14.7 Dongcheng Radiopharmaceutical Revenue by Geographic Area
4.14.8 Dongcheng Recent Development
4.15 Navidea
4.15.1 Navidea Corporation Information
4.15.2 Navidea Description, Business Overview
4.15.3 Navidea Radiopharmaceutical Products Offered
4.15.4 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.15.5 Navidea Radiopharmaceutical Revenue by Product
4.15.6 Navidea Radiopharmaceutical Revenue by Application
4.15.7 Navidea Radiopharmaceutical Revenue by Geographic Area
4.15.8 Navidea Recent Development
5 Breakdown Data by Type
5.1 Global Radiopharmaceutical Sales by Type (2015-2026)
5.1.1 Global Radiopharmaceutical Sales by Type (2015-2020)
5.1.2 Global Radiopharmaceutical Sales Forecast by Type (2021-2026)
5.1.3 Global Radiopharmaceutical Sales Market Share by Type (2015-2026)
5.2 Global Radiopharmaceutical Revenue Forecast by Type (2015-2026)
5.2.1 Global Radiopharmaceutical Revenue by Type (2015-2020)
5.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2021-2026)
5.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2015-2026)
5.3 Radiopharmaceutical Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Radiopharmaceutical Sales by Application (2015-2026)
6.1.1 Global Radiopharmaceutical Sales by Application (2015-2020)
6.1.2 Global Radiopharmaceutical Sales Forecast by Application (2021-2026)
6.1.3 Global Radiopharmaceutical Sales Market Share by Application (2015-2026)
6.2 Global Radiopharmaceutical Revenue Forecast by Application (2015-2026)
6.2.1 Global Radiopharmaceutical Revenue by Application (2015-2020)
6.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2021-2026)
6.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2015-2026)
6.3 Radiopharmaceutical Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Radiopharmaceutical Market Size YoY Growth 2015-2026
7.2 North America Radiopharmaceutical Market Facts & Figures by Country
7.2.1 North America Radiopharmaceutical Sales by Country (2015-2026)
7.2.2 North America Radiopharmaceutical Revenue by Country (2015-2026)
7.3 North America Radiopharmaceutical Sales by Type
7.4 North America Radiopharmaceutical Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Radiopharmaceutical Market Facts & Figures by Region
8.2.1 Asia-Pacific Radiopharmaceutical Sales by Region (2015-2026)
8.2.2 Asia-Pacific Radiopharmaceutical Revenue by Region (2015-2026)
8.3 Asia-Pacific Radiopharmaceutical Sales by Type
8.4 Asia-Pacific Radiopharmaceutical Sales by Application
9 Europe
9.1 Europe Radiopharmaceutical Market Size YoY Growth 2015-2026
9.2 Europe Radiopharmaceutical Market Facts & Figures by Country
9.2.1 Europe Radiopharmaceutical Sales by Country (2015-2026)
9.2.2 Europe Radiopharmaceutical Revenue by Country (2015-2026)
9.3 Europe Radiopharmaceutical Sales by Type
9.4 Europe Radiopharmaceutical Sales by Application
10 Latin America
10.1 Latin America Radiopharmaceutical Market Size YoY Growth 2015-2026
10.2 Latin America Radiopharmaceutical Market Facts & Figures by Country
10.2.1 Latin America Radiopharmaceutical Sales by Country (2015-2026)
10.2.2 Latin America Radiopharmaceutical Revenue by Country (2015-2026)
10.3 Latin America Radiopharmaceutical Sales by Type
10.4 Latin America Radiopharmaceutical Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Radiopharmaceutical Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
11.2.1 Middle East and Africa Radiopharmaceutical Sales by Country (2015-2026)
11.2.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2015-2026)
11.3 Middle East and Africa Radiopharmaceutical Sales by Type
11.4 Middle East and Africa Radiopharmaceutical Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Radiopharmaceutical Supply Chain Analysis
12.2 Radiopharmaceutical Key Raw Materials and Upstream Suppliers
12.3 Radiopharmaceutical Clients Analysis
12.4 Radiopharmaceutical Sales Channel and Sales Model Analysis
12.4.1 Radiopharmaceutical Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Radiopharmaceutical Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Radiopharmaceutical Distributors
13 Market Dynamics
13.1 Radiopharmaceutical Market Drivers
13.2 Radiopharmaceutical Market Opportunities
13.3 Radiopharmaceutical Market Challenges
13.4 Radiopharmaceutical Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Radiopharmaceutical Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
List of TablesTable 1. Global Radiopharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Actinium-225
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Holmium-166
Table 6. Major Manufacturers of Other
Table 7. Global Radiopharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Radiopharmaceutical Market Size by Region (US$ Million): 2020 VS 2026
Table 9. Global Radiopharmaceutical Sales by Region (2015-2020) & (M Doses)
Table 10. Global Radiopharmaceutical Sales Forecast by Region (2021-2026) & (M Doses)
Table 11. Global Radiopharmaceutical Revenue by Region (2015-2020) & (US$ Million)
Table 12. Global Radiopharmaceutical Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 13. Global Radiopharmaceutical Sales by Manufacturer (2015-2020) & (M Doses)
Table 14. Global Radiopharmaceutical Sales Share by Manufacturer (2015-2020)
Table 15. Radiopharmaceutical Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 16. Radiopharmaceutical Revenue Share by Manufacturer (2015-2020)
Table 17. Key Manufacturers Radiopharmaceutical Price (2015-2020) & (USD/Dose)
Table 18. Ranking of Global Top Radiopharmaceutical Manufacturers by Revenue (US$ Million) in 2019
Table 19. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 20. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2019)
Table 21. Radiopharmaceutical Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Radiopharmaceutical Product Type
Table 23. Date of International Manufacturers Enter into Radiopharmaceutical Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Bracco Imaging Corporation Information
Table 26. Bracco Imaging Description and Business Overview
Table 27. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 28. Bracco Imaging Radiopharmaceutical Product
Table 29. Bracco Imaging Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 30. Bracco Imaging Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 31. Bracco Imaging Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 32. Bracco Imaging Radiopharmaceutical Revenue (US$ Million) and Market Share by Sales Channel
Table 33. Bracco Imaging Recent Development
Table 34. Bayer Corporation Information
Table 35. Bayer Description and Business Overview
Table 36. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 37. Bayer Radiopharmaceutical Product
Table 38. Bayer Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 39. Bayer Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 40. Bayer Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 41. Bayer Radiopharmaceutical Revenue (US$ Million) and Market Share by Sales Channel
Table 42. Bayer Recent Development
Table 43. Mallinckrodt Corporation Information
Table 44. Mallinckrodt Description and Business Overview
Table 45. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 46. Mallinckrodt Radiopharmaceutical Product
Table 47. Mallinckrodt Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 48. Mallinckrodt Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 49. Mallinckrodt Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 50. Mallinckrodt Radiopharmaceutical Revenue (US$ Million) and Market Share by Sales Channel
Table 51. Mallinckrodt Recent Development
Table 52. Nordion Corporation Information
Table 53. Nordion Description and Business Overview
Table 54. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 55. Nordion Radiopharmaceutical Product
Table 56. Nordion Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 57. Nordion Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 58. Nordion Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 59. Nordion Radiopharmaceutical Revenue (US$ Million) and Market Share by Sales Channel
Table 60. Nordion Recent Development
Table 61. Triad Isotopes Corporation Information
Table 62. Triad Isotopes Description and Business Overview
Table 63. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 64. Triad Isotopes Radiopharmaceutical Product
Table 65. Triad Isotopes Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 66. Triad Isotopes Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 67. Triad Isotopes Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 68. Triad Isotopes Radiopharmaceutical Revenue (US$ Million) and Market Share by Sales Channel
Table 69. Triad Isotopes Recent Development
Table 70. Lantheus Corporation Information
Table 71. Lantheus Description and Business Overview
Table 72. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 73. Lantheus Radiopharmaceutical Product
Table 74. Lantheus Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 75. Lantheus Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 76. Lantheus Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 77. Lantheus Recent Development
Table 78. IBA Group Corporation Information
Table 79. IBA Group Description and Business Overview
Table 80. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. IBA Group Radiopharmaceutical Product
Table 82. IBA Group Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 83. IBA Group Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 84. IBA Group Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 85. IBA Group Recent Development
Table 86. GE Healthcare Corporation Information
Table 87. GE Healthcare Description and Business Overview
Table 88. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 89. GE Healthcare Radiopharmaceutical Product
Table 90. GE Healthcare Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 91. GE Healthcare Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 92. GE Healthcare Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 93. GE Healthcare Recent Development
Table 94. China Isotope & Radiation Corporation Information
Table 95. China Isotope & Radiation Description and Business Overview
Table 96. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. China Isotope & Radiation Radiopharmaceutical Product
Table 98. China Isotope & Radiation Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 99. China Isotope & Radiation Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 100. China Isotope & Radiation Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 101. China Isotope & Radiation Recent Development
Table 102. Jubilant Pharma Corporation Information
Table 103. Jubilant Pharma Description and Business Overview
Table 104. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 105. Jubilant Pharma Radiopharmaceutical Product
Table 106. Jubilant Pharma Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 107. Jubilant Pharma Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 108. Jubilant Pharma Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 109. Jubilant Pharma Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Eli Lilly Radiopharmaceutical Product
Table 114. Eli Lilly Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 115. Eli Lilly Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 116. Eli Lilly Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 117. Eli Lilly Recent Development
Table 118. Advanced Accelerator Applications Corporation Information
Table 119. Advanced Accelerator Applications Description and Business Overview
Table 120. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Advanced Accelerator Applications Radiopharmaceutical Product
Table 122. Advanced Accelerator Applications Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 123. Advanced Accelerator Applications Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 124. Advanced Accelerator Applications Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 125. Advanced Accelerator Applications Recent Development
Table 126. SIEMENS Corporation Information
Table 127. SIEMENS Description and Business Overview
Table 128. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 129. SIEMENS Radiopharmaceutical Product
Table 130. SIEMENS Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 131. SIEMENS Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 132. SIEMENS Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 133. SIEMENS Recent Development
Table 134. Dongcheng Corporation Information
Table 135. Dongcheng Description and Business Overview
Table 136. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 137. Dongcheng Radiopharmaceutical Product
Table 138. Dongcheng Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 139. Dongcheng Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 140. Dongcheng Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 141. Dongcheng Recent Development
Table 142. Navidea Corporation Information
Table 143. Navidea Description and Business Overview
Table 144. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 145. Navidea Radiopharmaceutical Product
Table 146. Navidea Radiopharmaceutical Revenue (US$ Million) and Market Share by Product
Table 147. Navidea Radiopharmaceutical Revenue (US$ Million) and Market Share by Application
Table 148. Navidea Radiopharmaceutical Revenue (US$ Million) and Market Share by Geographic Area
Table 149. Navidea Recent Development
Table 150. Global Radiopharmaceutical Sales by Type (2015-2020) & (M Doses)
Table 151. Global Radiopharmaceutical Sales Forecast by Type (2021-2026) & (M Doses)
Table 152. Global Radiopharmaceutical Revenue by Type (2015-2020) & (US$ Million)
Table 153. Global Radiopharmaceutical Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 154. Global Radiopharmaceutical Sales by Application (2015-2020) & (M Doses)
Table 155. Global Radiopharmaceutical Sales Forecast by Application (2021-2026) & (M Doses)
Table 156. Global Radiopharmaceutical Revenue by Application (2015-2020) & (US$ Million)
Table 157. Global Radiopharmaceutical Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 158. North America Radiopharmaceutical Sales by Country (2015-2020) & (M Doses)
Table 159. North America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 160. North America Radiopharmaceutical Revenue by Country (2015-2020) & (US$ Million)
Table 161. North America Radiopharmaceutical Revenue by Country (2021-2026) & (US$ Million)
Table 162. North America Radiopharmaceutical Sales by Type (2015-2020) & (M Doses)
Table 163. North America Radiopharmaceutical Sales by Application (2015-2020) & (M Doses)
Table 164. Asia-Pacific Radiopharmaceutical Sales by Region (2015-2020) & (M Doses)
Table 165. Asia-Pacific Radiopharmaceutical Sales by Region (2021-2026) & (M Doses)
Table 166. Asia-Pacific Radiopharmaceutical Revenue by Region (2015-2026) & (US$ Million)
Table 167. Asia-Pacific Radiopharmaceutical Revenue by Region (2021-2026) & (US$ Million)
Table 168. Asia-Pacific Radiopharmaceutical Sales by Type (2015-2020) & (M Doses)
Table 169. Asia-Pacific Radiopharmaceutical Sales by Application (2015-2020) & (M Doses)
Table 170. Europe Radiopharmaceutical Sales by Country (2015-2020) & (M Doses)
Table 171. Europe Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 172. Europe Radiopharmaceutical Revenue by Country (2015-2020) & (US$ Million)
Table 173. Europe Radiopharmaceutical Revenue by Country (2021-2026) & (US$ Million)
Table 174. Europe Radiopharmaceutical Sales by Type (2015-2020) & (M Doses)
Table 175. Europe Radiopharmaceutical Sales by Application (2015-2020) & (M Doses)
Table 176. Latin America Radiopharmaceutical Sales by Country (2015-2020) & (M Doses)
Table 177. Latin America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 178. Latin America Radiopharmaceutical Revenue by Country (2015-2020) & (US$ Million)
Table 179. Latin America Radiopharmaceutical Revenue by Country (2021-2026) & (US$ Million)
Table 180. Latin America Radiopharmaceutical Sales by Type (2015-2020) & (M Doses)
Table 181. Latin America Radiopharmaceutical Sales by Application (2015-2020) & (M Doses)
Table 182. Middle East and Africa Radiopharmaceutical Sales by Country (2015-2020) & (M Doses)
Table 183. Middle East and Africa Radiopharmaceutical Sales by Country (2021-2026) & (M Doses)
Table 184. Middle East and Africa Radiopharmaceutical Revenue by Country (2015-2020) & (US$ Million)
Table 185. Middle East and Africa Radiopharmaceutical Revenue by Country (2021-2026) & (US$ Million)
Table 186. Middle East and Africa Radiopharmaceutical Sales by Type (2015-2020) & (M Doses)
Table 187. Middle East and Africa Radiopharmaceutical Sales by Application (2015-2020) & (M Doses)
Table 188. Radiopharmaceutical Key Raw Materials, Industry Status and Trend
Table 189. Radiopharmaceutical Key Raw Materials and Upstream Suppliers
Table 190. Radiopharmaceutical Clients Status and Trend
Table 191. Radiopharmaceutical Typical Clients
Table 192. Radiopharmaceutical Distributors
Table 193. Key Drivers: Impact Analysis (2021-2026)
Table 194. Radiopharmaceutical Market Drivers
Table 195. Radiopharmaceutical Market Opportunities
Table 196. Radiopharmaceutical Market Challenges
Table 197. Radiopharmaceutical Market Restraints
Table 198. Radiopharmaceutical Porter’s Five Forces Analysis
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales Market Share by Type in 2020 & 2026
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Sales Market Share by Application in 2020 & 2026
Figure 9. Oncology Examples
Figure 10. Cardiology Examples
Figure 11. Other Examples
Figure 12. Radiopharmaceutical Report Years Considered
Figure 13. Global Radiopharmaceutical Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 14. Global Radiopharmaceutical Market Size 2015-2026 (US$ Million)
Figure 15. Global Radiopharmaceutical Sales 2015-2026 (K Units)
Figure 16. Global Radiopharmaceutical Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Radiopharmaceutical Sales Market Share Forecast by Region (2015-2026)
Figure 18. Global Radiopharmaceutical Revenue Market Share by Region (2015-2026)
Figure 19. Global Radiopharmaceutical Sales Share by Manufacturer in 2019
Figure 20. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Radiopharmaceutical Sales Market Share Forecast by Type (2015-2026)
Figure 22. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2015-2026)
Figure 23. Radiopharmaceutical Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)
Figure 24. Global Radiopharmaceutical Sales Market Share Forecast by Application (2015-2026)
Figure 25. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2015-2026)
Figure 26. Radiopharmaceutical Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)
Figure 27. North America Radiopharmaceutical Revenue 2015-2026 (US$ Million)
Figure 28. North America Radiopharmaceutical Sales Market Share by Type (2015-2020)
Figure 29. North America Radiopharmaceutical Sales Market Share by Application (2015-2020)
Figure 30. Asia-Pacific Radiopharmaceutical Revenue 2015-2026 (US$ Million)
Figure 31. Asia-Pacific Radiopharmaceutical Sales Market Share by Region (2015-2026)
Figure 32. Asia-Pacific Radiopharmaceutical Revenue Market Share by Region (2015-2026)
Figure 33. Asia-Pacific Radiopharmaceutical Sales Market Share by Type (2015-2020)
Figure 34. Asia-Pacific Radiopharmaceutical Sales Market Share by Application (2015-2020)
Figure 35. Europe Radiopharmaceutical Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. Europe Radiopharmaceutical Sales Market Share by Country (2015-2026)
Figure 37. Europe Radiopharmaceutical Revenue Market Share by Country (2015-2026)
Figure 38. Europe Radiopharmaceutical Sales Market Share by Type (2015-2020)
Figure 39. Europe Radiopharmaceutical Sales Market Share by Application (2015-2020)
Figure 40. Latin America Radiopharmaceutical Revenue Growth Rate 2015-2026 (US$ Million)
Figure 41. Latin America Radiopharmaceutical Sales Market Share by Country (2015-2026)
Figure 42. Latin America Radiopharmaceutical Revenue Market Share by Country (2015-2020)
Figure 43. Latin America Radiopharmaceutical Sales Market Share by Type (2015-2020)
Figure 44. Latin America Radiopharmaceutical Sales Market Share by Application (2015-2020)
Figure 45. Middle East and Africa Radiopharmaceutical Revenue Growth Rate 2015-2026 (US$ Million)
Figure 46. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2015-2026)
Figure 47. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2015-2026)
Figure 48. Middle East and Africa Radiopharmaceutical Sales Market Share by Type (2015-2020)
Figure 49. Middle East and Africa Radiopharmaceutical Sales Market Share by Application (2015-2020)
Figure 50. Radiopharmaceutical Supply Chain (Upstream and Downstream Market)
Figure 51. Global Production Market Share of Radiopharmaceutical Raw Materials by Region in 2019
Figure 52. Radiopharmaceutical Distribution Channels
Figure 53. Global Radiopharmaceutical Percentage 2015-2026: Indirect Sales VS Direct Sales
Figure 54. Global Radiopharmaceutical Percentage 2015-2026: Online Sales VS Offline Sales
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
